1. Wikenheiser-Brokamp, K. A. Retinoblastoma regulatory pathway in lung cancer. Curr. Mol. Med. 6, 783–793 (2006). Review.
2. Harris, T. J. R. & McCormick, F. The molecular pathology of cancer. Nat. Rev. Clin. Oncol. 7, 251–265 (2010).
3. Okada, A., Shimmyo, T., Hashimoto, T., Kobayashi, Y., Miyagi, Y., Ishikawa, Y. et al. Predictive advantage of a cell type classification for pulmonary adenocarcinoma coupled with data for p53, K-ras and EGFR alterations. Cancer Sci. 101, 1745–1753 (2010).
4. Colby, T. V., Noguchi, M., Henschke, C., Vazquez, M. F., Geisinger, K., Yokose, T. et al. Adenocarcinoma. In: World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart (eds. Travis, W.D., Brambilla, E., Muller-Hermelink, H.K., Harris, C.C.). 35–44 (IACR Press, Lyon, 2003).
5. Silver, S. A. & Askin, F. S. True papillary carcinoma of the lung: a distinct cliniclpathologic entity. Am. J. Surg. Pathol. 21, 43–51 (1997).